Literature DB >> 7933812

Immunohistochemical localization of collagen VI in diabetic glomeruli.

A G Nerlich1, E D Schleicher, I Wiest, U Specks, R Timpl.   

Abstract

Late stage diabetic nephropathy is histologically characterized by either diffuse or nodular expansion of the glomerular matrix. This is presumed to represent the morphological correlate for the functional impairment of the kidney. The exact matrix composition of the nodular glomerulosclerosis lesion of end-stage diabetic nephropathy is not known. Biochemical studies have provided evidence that the microfibrillar collagen type VI is increased in diabetic nephropathy. Consequently, this immunohistochemical study was designed to evaluate the extent and exact morphologic location of increased collagen VI deposition at various stages of diabetic glomerulosclerosis (GS). An irregular, sometimes spot-like staining of collagen VI was observed in diffuse GS in the mesangial portion. The uninterrupted staining which was evident along the glomerular basement membrane in normal glomeruli was discontinuous in diffusely sclerotic glomeruli. In nodular GS, the markedly increased deposition of collagen VI appeared to be evenly distributed throughout the entire nodular lesion. At the same time, mesangial staining for collagen IV was reduced in nodular GS, suggesting that in the expanded mesangial matrix collagen IV is progressively substituted by collagen VI during the transition from diffuse to nodular GS. The colocalization of PAS staining with collagen VI deposition in nodular GS suggests that the typical Kimmelstiel-Wilson lesions at least in part consist of collagen VI. Biochemical analysis confirmed the increased collagen VI deposition in glomeruli extracted from diabetic patients with nodular GS. Application of two antisera, recognizing primarily the alpha 1(VI)- and alpha 2(VI)-chains and the N-terminal part of alpha 3(VI)-chain, respectively, revealed no difference in staining pattern.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933812     DOI: 10.1038/ki.1994.216

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Immunohistochemical distribution of type VI collagen in developing human kidney.

Authors:  G Magro; S Grasso; A Colombatti; M Lopes
Journal:  Histochem J       Date:  1996-05

Review 3.  The impact of insulin resistance on the kidney and vasculature.

Authors:  Ferruh Artunc; Erwin Schleicher; Cora Weigert; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

4.  Mast cells and type VIII collagen in human diabetic nephropathy.

Authors:  B M Rüger; Q Hasan; N S Greenhill; P F Davis; P R Dunbar; T J Neale
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

5.  High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.

Authors:  V Kolm-Litty; U Sauer; A Nerlich; R Lehmann; E D Schleicher
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Urinary endotrophin predicts disease progression in patients with chronic kidney disease.

Authors:  Daniel Guldager Kring Rasmussen; Anthony Fenton; Mark Jesky; Charles Ferro; Peter Boor; Martin Tepel; Morten Asser Karsdal; Federica Genovese; Paul Cockwell
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

7.  Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease.

Authors:  Anthony Fenton; Mark D Jesky; Charles J Ferro; Jacob Sørensen; Morten A Karsdal; Paul Cockwell; Federica Genovese
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

8.  Glucose fluctuation increased mesangial cell apoptosis related to AKT signal pathway.

Authors:  Changjiang Ying; Shanshan Wang; Yan Lu; Lei Chen; Yizhen Mao; Hongwei Ling; Xingbo Cheng; Xiaoyan Zhou
Journal:  Arch Med Sci       Date:  2019-04-30       Impact factor: 3.318

9.  Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells.

Authors:  Maria E Vega; John B Finlay; Mansi Vasishtha; Jean E Schwarzbauer
Journal:  Matrix Biol Plus       Date:  2020-09-30

Review 10.  Drug-induced nephrotoxicity and its biomarkers.

Authors:  Sun Young Kim; Aree Moon
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.